UTI Nifty India Manufacturing Index Fund

A Equity Funds scheme from UTI Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF789F1AB48).

NAV ₹12.3520 on 16 November 2026.

Expense ratio

Total expense ratio 0.72% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 0.50%, brokerage 0.01%, transaction costs 0.00%, statutory levies including GST 0.21%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year4.5%16.5%-12.9%-0.15-0.15

Too little NAV history for the 3, 5, 10-year figures.

Not ranked in its category: its category mixes funds too different to rank against one another.

Largest holdings

Top 10 (September 2026 disclosure). Company shares make up 100.0% of the portfolio.

  1. Mahindra & Mahindra Limited — 4.99%
  2. Reliance Industries Limited — 4.97%
  3. Sun Pharmaceutical Industries Limited — 4.60%
  4. Maruti Suzuki India Limited — 3.72%
  5. Tata Steel Limited — 3.66%
  6. Bharat Electronics Limited — 3.33%
  7. Hindalco Industries Limited — 3.26%
  8. JSW Steel Limited — 2.89%
  9. Bajaj Auto Limited — 2.84%
  10. Divi's Laboratories Limited — 2.82%

Plans

Other funds in Equity Funds

All 88 funds in Equity Funds · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.